Top Markets
Coin of the day
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Rangering i aksjer #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Aksjekurs
$45.79
Markedsverdi
$2.33B
Endring (1 dag)
11.43%
Endring (1 år)
408.10%
Land
FR
Handel Nanobiotix S.A. (NANO)

Kategori

Historikk for aksjesplitt for Nanobiotix S.A. (NANO)
Aksjen Nanobiotix S.A. (symbol: NANO) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 27, 2026.
Én NANO-aksje kjøpt før Aug 27, 2026 tilsvarer i dag 0 NANO-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH